Observational Study of NovoNorm® in Subjects With Diabetes
NCT01498913
·
clinicaltrials.gov ↗
COMPLETED
Status
5841
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
repaglinide
Sponsor
Novo Nordisk A/S